SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Blyth, Inc. (BTH), Align Technology, Inc. (ALGN) and

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Blyth,
    Inc. (BTH), Align Technology, Inc. (ALGN) and Abiomed, Inc. (ABMD) and
           Investigation of Peregrine Pharmaceuticals, Inc. (PPHM)

PR Newswire

NEW YORK, Dec. 5, 2012

NEW YORK, Dec. 5, 2012 /PRNewswire/ --

Blyth, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in
the USDC for the District of Connecticut on behalf of investors who purchased
Blyth, Inc. (NYSE: BTH) stock between March 14, 2012 and November 6, 2012.

For more information, click here: http://zlk.9nl.com/blyth-bth. You have
until January 12, 2013  to request that the Court appoint you as lead
plaintiff.

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )

Align Technology, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in
the United States District Court for the Northern District of California on
behalf of investors who acquired Align Technology, Inc. (NasdaqGS: ALGN)
securities between April 23, 2012 and October 17, 2012.

For more information, click here: http://zlk.9nl.com/align-technology-algn/.
You have until January 28, 2013  to request that the Court appoint you as lead
plaintiff.

Abiomed, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in
the United States District Court for the District of Massachusetts on behalf
of investors who purchased Abiomed, Inc. (Nasdaq: ABMD) stock between August
5, 2011 and October 31, 2012.

For more information, click here: http://zlk.9nl.com/abiomed-abmd. 

Peregrine Pharmaceuticals, Inc.
Levi & Korsinsky is investigating potential claims on behalf of purchasers of
Peregrine Pharmaceuticals, Inc. (NasdaqCM: PPHM) securities concerning
possible breaches of fiduciary duty in connection with the disclosure of the
discovery of major discrepancies in the treatment group of its Bavituxmab
Phase II Second-Line Non-Small Cell Lung Cancer Trial.

For more information, click here:
http://zlk.9nl.com/peregrine-pharmaceuticals-pphm/. 

Levi & Korsinsky is a national firm with offices in New York and Washington
D.C. The firm has extensive expertise in prosecuting securities litigation
involving financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. Attorney advertising. Prior results do
not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP

Website: http://www.zlk.com
 
Press spacebar to pause and continue. Press esc to stop.